ARTICLE SUMMARY:
A companion article to "Devices for Many-Faceted Heart Failure." CorInnova's thin-film device is able to deliver active cardiac compressions without contacting blood. opening treatment to hundreds of thousands of heart failure patients without good options.
Now, on the eve of its first-in-human studies, CorInnova has developed a minimally invasive mechanical circulatory-assist device that respects the natural physiology of the heart. It is disruptive because it provides active cardiac support without requiring contact with blood, a source of complications for existing left ventricular assist devices (LVADs) and other mechanical circulatory support devices for heart failure.
The device was conceived by its inventor, John Criscione, MD, PhD, a biomedical engineer and a professor in the Department of Biomedical Engineering at Texas A&M University, to restore healthy motion to the hearts of patients after a damaging myocardial infarction (MI), to prevent them from progressing to heart failure. Since then, the company has uncovered many other valuable opportunities in heart failure, where its current device has the ideal attributes for temporary cardiac assist, and the potential to be developed for long-term heart support.
